Skip to main content

Health condition · Clinically reviewed

Neurofibromatosis type 2, bilateral vestibular schwannomas - and a lifelong plan to protect hearing.

A rare genetic condition, much rarer than NF1, that needs coordinated specialist care rather than a single fix. Early hearing checks and regular MRI surveillance make the biggest difference.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against NHS England commissioning policy and peer-reviewed sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK care through specialist commissioned complex NF2 services, including bevacizumab and implant options.

Key facts

NF2 at a glance.

The essentials, in plain English - what it is, why it happens, and how UK specialist services manage it today.

  • What it is

    A rare genetic condition causing benign tumours on nerves - most characteristically bilateral vestibular schwannomas on the hearing and balance nerves.

  • Also called

    NF2-related schwannomatosis - a name change reflecting a better understanding of how the condition behaves.

  • Cause

    A mutation in the NF2 gene on chromosome 22, which normally makes a tumour-suppressing protein called merlin.

  • How rare

    Roughly 1 in 25,000 to 40,000 people - far rarer than neurofibromatosis type 1.

  • First symptom

    Often hearing loss or tinnitus on one side, though juvenile cataracts can appear even earlier.

  • Care model

    Lifelong monitoring through an NHS England designated specialist NF2 centre, not a single one-off treatment.

Why this guide matters

A rare condition, easy to miss early on.

Because NF2 is so rare, symptoms are often put down to something else first. The three points below shape everything else on this page.

  • Hearing loss is often the first clue

    One-sided hearing loss or tinnitus in a young adult deserves an MRI, not just a hearing aid - especially with any family history.

  • Surveillance protects hearing better than surgery alone

    Regular MRI scanning lets specialists intervene at the right moment, rather than reacting to a crisis.

  • This is lifelong specialist care

    NHS England commissioned complex NF2 clinics coordinate audiology, neurosurgery, ophthalmology and genetics in one team.

How the diagnosis is made

From first symptoms to specialist care.

The steps a UK audiology, ophthalmology or genetics team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    Hearing and balance assessment

    Audiology testing is often the first step, prompted by one-sided hearing loss, tinnitus or unsteadiness.

  2. 02

    Assessing

    Eye examination

    Ophthalmology checks for juvenile posterior subcapsular cataracts, which can appear before any hearing symptoms.

  3. 03

    Assessing

    Family history review

    NF2 is autosomal dominant, so a parent, sibling or child with the condition raises the index of suspicion considerably.

  4. 04

    Confirming

    MRI brain with internal auditory meatus views

    The key investigation - looking specifically for vestibular schwannomas and other intracranial tumours such as meningiomas.

  5. 05

    Confirming

    MRI whole spine

    Checks for spinal ependymomas and schwannomas, which are common elsewhere in the nervous system.

  6. 06

    Referring

    Applying the Manchester criteria

    Bilateral vestibular schwannomas confirm the diagnosis outright, or a family history plus one vestibular schwannoma or other qualifying tumour.

  7. 07

    Referring

    Genetic testing and specialist referral

    Blood testing confirms the NF2 mutation and referral follows to an NHS England specialist commissioned complex NF2 clinic for lifelong care.

Typical timeline: weeks from first hearing test to a specialist NF2 clinic appointment, once imaging confirms the picture.

Symptoms

What NF2 actually looks like.

Hearing and balance symptoms dominate, but other nerve tumours and eye changes matter too. And the features that mean it’s time to escalate.

  • Hearing loss

    Usually gradual and one-sided at first, from a vestibular schwannoma pressing on the hearing nerve. Often the earliest noticed symptom.

  • Tinnitus

    Ringing, buzzing or hissing in one ear, frequently alongside or before measurable hearing loss.

  • Balance problems and dizziness

    Unsteadiness or vertigo as the tumour affects the vestibular part of the nerve, not just hearing.

  • Facial weakness or numbness

    Larger tumours can press on the nearby facial nerve, causing weakness, numbness or altered taste.

  • Other nerve tumours

    Meningiomas, spinal ependymomas and further schwannomas can develop elsewhere in the brain and spinal cord.

  • Skin tumours

    Fewer and less prominent than in NF1 - small, firm nodules or slightly raised patches on the skin.

  • Juvenile cataracts

    Posterior subcapsular cataracts can appear in childhood or the teenage years, sometimes before any hearing symptoms at all.

  • Red flag - sudden hearing loss

    A sudden drop in hearing or new facial weakness needs prompt specialist assessment, not a wait-and-see approach.

Treatment

How NF2 is managed in the UK.

Surveillance first, hearing preservation wherever possible, and a specialist MDT coordinating every decision along the way.

  • Regular MRI surveillance

    Annual or more frequent scans of the brain and spine track tumour growth over time and guide every other decision.

  • Hearing preservation strategy

    Watchful waiting, radiosurgery or surgery depending on tumour size, growth rate and current hearing - chosen carefully to protect what hearing remains.

  • Bevacizumab (anti-VEGF)

    A hearing-preservation option for growing vestibular schwannomas, given as an alternative to surgery in selected NHS England commissioned cases.

  • Cochlear implant

    Considered where the hearing nerve is intact but hearing loss is disabling, particularly after tumour removal.

  • Auditory brainstem implant

    An option when the hearing nerve itself cannot be preserved, most often after bilateral vestibular schwannoma surgery.

  • Surgery for other tumours

    Meningiomas and spinal tumours are removed when they cause symptoms or threaten neurological function, timed to minimise harm.

  • Ophthalmology monitoring

    Regular eye checks track cataracts and other ocular findings, with surgery offered if vision is significantly affected.

  • Genetic counselling

    Supports family planning decisions, explains the roughly 50% inheritance risk, and can involve prenatal or pre-implantation testing.

What this guide is based on

The sources behind every claim on this page.

UK national commissioning policy and specialist diagnostic criteria, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your specialist NF2 team knows your scans and history and can tell you which parts apply to you. If in doubt, get seen.

  • NHS England. Clinical commissioning policy for neurofibromatosis type 2 services, including bevacizumab.

  • Evans DG et al. Genetic and clinical diagnostic criteria for neurofibromatosis type 2 (Manchester criteria).

  • NHS England. National Genomic Test Directory - NF2-related schwannomatosis.

  • Neuro Foundation UK. Patient information on NF2-related schwannomatosis.

Red flags

When NF2 needs urgent attention.

Most NF2 care is planned and scheduled. These are the situations that aren’t - and where a same-day or urgent specialist opinion is needed.

  • Sudden hearing loss

    A rapid drop in hearing, rather than a slow decline, warrants urgent review by the specialist NF2 team.

  • New facial weakness or numbness

    Suggests the facial nerve is under pressure - a sign that a tumour may be growing and needs reassessment.

  • Signs of raised pressure in the skull

    Persistent headache, vomiting or visual disturbance can signal a larger intracranial tumour needing prompt imaging.

  • Spinal cord compression signs

    New limb weakness, numbness, or bladder or bowel changes from a spinal ependymoma or schwannoma need same-day assessment.

  • Rapid tumour growth on MRI

    A significant change between scans should prompt an earlier specialist discussion about treatment timing.

  • Sudden vision changes

    Rapid deterioration in sight, beyond the usual slow progression of cataracts, needs urgent ophthalmology input.

  • Bevacizumab side effects

    Unusual bleeding, very high blood pressure or poor wound healing while on treatment should be reported to the specialist team without delay.

  • New neurological deficit of any kind

    Any unexplained weakness, sensory change or coordination problem deserves rapid reassessment rather than waiting for the next routine scan.

  • Planning a pregnancy without genetic counselling

    NF2 carries a roughly 50% inheritance risk per pregnancy - counselling before conceiving allows informed choices about testing.

Living with it

A rare condition, with a clear team behind you.

Four things that make the biggest difference over the years - accepting surveillance as routine, planning for hearing early, thinking ahead about family, and knowing who to call.

A quiet reminder

You are not managing this alone.

A specialist commissioned NF2 team exists precisely because this condition needs several kinds of expertise working together.

  1. 01 Routine

    Surveillance becomes part of life

    Regular MRI scans and specialist clinic appointments are not a phase - they are the backbone of managing NF2 well for decades.

  2. 02 Hearing

    Plan for communication early

    Lip reading, sign language, hearing aids or implants are worth exploring before hearing loss becomes severe, not after.

  3. 03 Family

    Talk to genetics before you plan a family

    Understanding the inheritance risk and testing options in advance makes family planning far less daunting.

  4. 04 Escalate

    Know your specialist centre

    Keep the contact details for your NHS England NF2 centre to hand - new symptoms deserve a call, not a wait for the next scheduled visit.

Frequently asked

Everything we get asked about NF2.

Quick answers on diagnosis, hearing preservation, bevacizumab and family planning.

  • What is neurofibromatosis type 2 (NF2)?

    A rare autosomal dominant genetic condition, also known as NF2-related schwannomatosis, caused by a mutation in the NF2 gene. It causes benign tumours on nerves, most characteristically bilateral vestibular schwannomas affecting hearing and balance.

  • How is NF2 different from NF1?

    They are caused by different genes and behave differently. NF1 is far more common and usually involves café-au-lait patches and neurofibromas of the skin, while NF2 is much rarer and is defined by bilateral vestibular schwannomas along with meningiomas, spinal tumours and juvenile cataracts.

  • Will I definitely need surgery for vestibular schwannomas?

    Not always. Small, slow-growing tumours with stable hearing are often monitored with watchful waiting. Surgery, radiosurgery or bevacizumab are considered when the tumour grows, hearing declines, or other symptoms develop.

  • What is bevacizumab and how does it help?

    Bevacizumab is an anti-VEGF drug given by infusion that can shrink growing vestibular schwannomas and, in many patients, help preserve hearing as an alternative to surgery. It is available through NHS England commissioned specialist NF2 services for selected patients.

  • Can NF2 be inherited, or does it always run in families?

    It is autosomal dominant, so each child of an affected parent has roughly a 50% chance of inheriting it. However, around half of new diagnoses arise from a new mutation with no family history at all.

  • What monitoring will I need for life?

    Regular MRI scans of the brain and spine, ongoing audiology assessment, and periodic ophthalmology review, coordinated through a specialist commissioned complex NF2 clinic. The frequency depends on tumour behaviour and is adjusted over time.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.